Transformation of 3rd Party Risk Management


AstraZeneca is dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. To do so, we need high confidence across our activities and also those of our third parties.

We transformed our third party risk process in 2022. The was a highly complex programme, integrating multiple processes/platforms and leveraging significant automation to deliver targeted due diligence. Benefits include a sharp reduction in user input and turnaround times, a five-fold increase in due diligence, and far more comprehensive scope. A great step forward for AstraZeneca and for our patients.